Gene Therapy - Developments and Future Perspectives
Edited by Chunsheng Kang, ISBN 978-953-307-617-1, Hard cover, 356 pages, Publisher: InTech, Published: June 22, 2011 under CC BY-NC-SA 3.0 license, in subject Medical Genetics
DOI: 10.5772/748
DOI: 10.5772/748
The aim of this book is to cover key aspects of existing problems in the field of development and future perspectives in gene therapy. Contributions consist of basic and translational research, as well as clinical experiences, and they outline functional mechanisms, predictive approaches, patient-related studies and upcoming challenges in this stimulating but also controversial field of gene therapy research. This source will make our doctors become comfortable with the common problems of gene therapy and inspire others to delve a bit more deeply into a topic of interest.
This book is indexed in:
BOOK CONTENTS
- Chapter 1 New Vectors for Stable and Safe Gene Modification
- Chapter 2 Gene Therapy Using RNAi
- Chapter 3 Scalable Technology to Produce Pharmaceutical Grade Plasmid DNA for Gene Therapy
- Chapter 4 Small interfering RNAs: heralding a new era in gene therapy
- Chapter 5 MiRNAs-based Gene Therapy on the Horizon: Novel and Effective Therapeutic Advancement
- Chapter 6 Gene Therapy Strategies Incorporating Large Transgenes
- Chapter 7 Recent Advances and Improvements in the Biosafety of Gene Therapy
- Chapter 8 Impacts of DNA Microarray Technology in Gene Therapy
- Chapter 9 Hopes and Disillusions in Therapeutic Targeting of Intercellular Communication in Cancer.
- Chapter 10 Promising Role of Engineered Gene Circuits in Gene Therapy
- Chapter 11 Comparison of DNA Delivery and Expression Using Frequently Used Delivery Methods
- Chapter 12 Preclinical and Clinical Prospects of Gene Therapy in Myocardial Infarction
- Chapter 13 Gene Therapy for Therapeutic Angiogenesis
- Chapter 14 Cancer Gene Therapy- Developments and Future Perspectives
- Chapter 15 Differential Gene Expression and Its Possible Therapeutic Implications
- Chapter 16 Engineered Drug Resistant Cell-Mediated Immunotherapy
No comments:
Post a Comment